Clinical Conversations » Podcast Feed
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:24
- More information
Informações:
Synopsis
Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored the use of a monoclonal antibody–drug conjugate (trastuzumab–deruxtecan) in patients with disease they classify as HER2-“low.” Compared […] The post Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate first appeared on Clinical Conversations.